Millions of people around the world take medication every day to control high blood pressure and reduce their risk of heart attacks and strokes.
One of the most commonly prescribed groups of blood pressure medicines is known as calcium channel blockers, often shortened to CCBs.
These drugs help relax and widen blood vessels, making it easier for blood to flow and reducing pressure on the heart.
Now, a large new study has raised questions about whether these medications could be linked to an increased risk of glaucoma, a serious eye disease that can gradually damage vision.
The research was led by Dr. Alan Kastner and colleagues at Moorfields Eye Hospital and University College London.
Their findings were published in the journal JAMA Ophthalmology and have attracted attention because of the large number of people who rely on calcium channel blockers to manage their blood pressure.
The researchers analyzed health information from more than 427,000 adults in the United Kingdom. Among these participants, about 33,000 people were taking calcium channel blockers. The team compared the eye health of people using these medications with those who were not taking them.
After accounting for factors such as age, lifestyle habits, and other medical conditions, the researchers found that people taking calcium channel blockers were more likely to develop glaucoma than people who were not using these medicines.
One particularly interesting finding was that the increased risk appeared to be specific to calcium channel blockers. Other types of blood pressure medications did not show the same association. This suggests that there may be something unique about the way calcium channel blockers affect the eyes.
The results also challenged a long-standing belief about glaucoma. Traditionally, glaucoma has been strongly linked to high pressure inside the eye. Elevated eye pressure is considered one of the most important risk factors for the disease.
However, the researchers found that the increased glaucoma risk among calcium channel blocker users was present even in people whose eye pressure remained normal.
This finding suggests that glaucoma may sometimes develop through mechanisms other than increased eye pressure. It also raises the possibility that calcium channel blockers could affect the optic nerve in ways that scientists do not yet fully understand.
Glaucoma is one of the leading causes of blindness worldwide. The disease damages the optic nerve, which carries visual information from the eye to the brain. As the optic nerve becomes damaged, vision can gradually deteriorate. In many cases, people do not notice symptoms during the early stages of the disease.
This silent progression makes glaucoma particularly dangerous. By the time noticeable vision problems appear, permanent damage may already have occurred. For this reason, regular eye examinations are considered one of the most important ways to detect glaucoma early.
The exact reason why calcium channel blockers might be linked to glaucoma remains unclear. The researchers emphasized that their study only found an association between the medication and the disease. It does not prove that calcium channel blockers directly cause glaucoma.
There may be other explanations for the findings. For example, people who take calcium channel blockers could differ from other patients in ways that are difficult to fully measure. Additional studies will be needed to determine whether the medication itself contributes to glaucoma risk or whether other factors are involved.
Scientists are now interested in exploring how calcium channel blockers might affect blood flow to the optic nerve. Some experts believe that changes in circulation could potentially play a role in glaucoma development, even when eye pressure remains normal. Future research may help clarify whether this is part of the explanation.
The researchers recommend that people taking calcium channel blockers should not stop their medication without speaking to their doctor.
High blood pressure is a serious condition that can lead to heart disease, stroke, kidney disease, and other health problems if left untreated. For many patients, these medications provide important benefits that may outweigh any potential risks.
Instead, the findings highlight the importance of regular eye care. People taking calcium channel blockers may wish to discuss glaucoma screening with their doctor or eye specialist, especially if they have other risk factors such as older age, a family history of glaucoma, diabetes, or existing eye problems.
The study also noted that some researchers involved had financial relationships with pharmaceutical companies. While this does not invalidate the findings, transparency about potential conflicts of interest helps readers evaluate research more carefully.
Overall, this large study provides important new information about a possible connection between calcium channel blockers and glaucoma. While more research is needed before any firm conclusions can be reached, the findings serve as a reminder that medications can sometimes have unexpected effects beyond their primary purpose.
For patients, the message is simple: continue taking prescribed medications as directed, attend regular medical appointments, and do not overlook routine eye examinations. Detecting glaucoma early can help preserve vision and reduce the risk of permanent sight loss.
If you care about high blood pressure, please read studies about unhealthy habits that may increase high blood pressure risk, and drinking green tea could help lower blood pressure.
For more information about high blood pressure, please see recent studies about what to eat or to avoid for high blood pressure, and 12 foods that lower blood pressure.
